Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GW Pharma rises after analyst sees promise in marijuana-derived epilepsy drug
GW Pharma rises after analyst sees promise in marijuana-derived epilepsy drug
GW Pharma rises after analyst sees promise in marijuana-derived epilepsy drug
Submitted by
admin
on June 30, 2014 - 11:56am
Source:
The Fly on the Wall
News Tags:
GW Pharma
epilpesy
marijuana
Epidiolex
Headline:
GW Pharma rises after analyst sees promise in marijuana-derived epilepsy drug
Do Not Allow Advertisers to Use My Personal information